Guideline on the Evaluation of Medicinal Products Indicated for Treatment of Bacterial Infections

On 24 May 2022 the EMA published the revised guideline on the evaluation of human medicines for the treatment of bacterial infections, revision 3.

This guideline merges, revises and adds to the guidance previously included in the Guideline on the evaluation of medicinal products indicated for treatment of bacterial infections (CPMP/EWP/558/95 Rev 2) and the Addendum to the guideline on the evaluation of medicinal products indicated for treatment of bacterial infections (EMA/CHMP/351889/2013).

Read the pdf 
Copyright Widler & Schiemann AG 2020. All Rights Reserved. /